Answers are grounded in this paper and cite their sources.
The aberrant assembly of amyloid-β (Aβ) is implicated in Alzheimer's disease (AD). Recent clinical outcomes of Aβ-targeted immunotherapy reinforce the notion that clearing Aβ burden is a potential therapeutic approach for AD. Herein, to develop drug candidates for chemically driven clearance of Aβ aggregates, we synthesized 51 novel polyfunctionalized furo[2,3-
No takes yet. Share an insight, caveat, or question.
Cha et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: